JP2023544620A5 - - Google Patents

Info

Publication number
JP2023544620A5
JP2023544620A5 JP2023521437A JP2023521437A JP2023544620A5 JP 2023544620 A5 JP2023544620 A5 JP 2023544620A5 JP 2023521437 A JP2023521437 A JP 2023521437A JP 2023521437 A JP2023521437 A JP 2023521437A JP 2023544620 A5 JP2023544620 A5 JP 2023544620A5
Authority
JP
Japan
Prior art keywords
weeks
pharmaceutical composition
subject
composition according
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023521437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544620A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/059211 external-priority patent/WO2022074603A1/en
Publication of JP2023544620A publication Critical patent/JP2023544620A/ja
Publication of JP2023544620A5 publication Critical patent/JP2023544620A5/ja
Pending legal-status Critical Current

Links

JP2023521437A 2020-10-09 2021-10-07 抗il12/il23抗体によるクローン病のための治療方法 Pending JP2023544620A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063089786P 2020-10-09 2020-10-09
US63/089,786 2020-10-09
US202163235188P 2021-08-20 2021-08-20
US63/235,188 2021-08-20
PCT/IB2021/059211 WO2022074603A1 (en) 2020-10-09 2021-10-07 Method for treating crohn's disease with anti-il12/il23 antibody

Publications (2)

Publication Number Publication Date
JP2023544620A JP2023544620A (ja) 2023-10-24
JP2023544620A5 true JP2023544620A5 (https=) 2024-10-15

Family

ID=81078738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521437A Pending JP2023544620A (ja) 2020-10-09 2021-10-07 抗il12/il23抗体によるクローン病のための治療方法

Country Status (10)

Country Link
US (1) US20220112282A1 (https=)
EP (1) EP4225350A4 (https=)
JP (1) JP2023544620A (https=)
KR (1) KR20230084283A (https=)
CN (1) CN116348491A (https=)
AU (1) AU2021356282A1 (https=)
CA (1) CA3198413A1 (https=)
IL (1) IL301944A (https=)
MX (1) MX2023004017A (https=)
WO (1) WO2022074603A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111471655B (zh) * 2020-03-19 2023-07-07 湖州正熙医学检验实验室有限公司 抗人il12/23稳转细胞株及其构建方法和应用
WO2025024237A2 (en) * 2023-07-21 2025-01-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of il-12 related biomarkers and il-12 specific blocking antibodies for the treatment of an autoimmune disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA54562A (fr) * 2018-12-18 2021-10-27 Janssen Biotech Inc Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23

Similar Documents

Publication Publication Date Title
JP2022534020A5 (https=)
JP2019523295A5 (https=)
JP6097888B2 (ja) 新規使用
JP7288927B2 (ja) 乾癬性関節炎患者における構造的損傷の進行を阻害するためのil-17アンタゴニストの使用
JP2023528265A5 (https=)
JP2021515770A5 (https=)
JP2024520202A5 (https=)
IL316408A (en) A safe and effective method for treating psoriasis with a specific anti-IL23 antibody
JP2020502261A5 (https=)
JP2023527542A5 (https=)
JP2022525164A5 (https=)
IL310216A (en) Methods of treating crohn's disease with anti-il23 specific antibody
JP2023544620A5 (https=)
JP2024537864A5 (https=)
JP2022536088A5 (https=)
JP2022529929A5 (https=)
JP2024518536A5 (https=)
JP2021532176A5 (https=)
JP2021530697A5 (https=)
CN120731227A (zh) 使用抗ctla4抗体治疗结直肠癌的方法
JP7794807B2 (ja) 気道疾患の治療に使用するための(1r,3s)-3-((5-シアノ-4-フェニルチアゾール-2-イル)カルバモイル)シクロペンタン-1-カルボン酸およびその誘導体
JP2023514567A5 (https=)
JP2022514561A5 (https=)
JP2023524125A5 (https=)
WO2023008530A1 (ja) 新型コロナウイルス感染症治療剤